You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Krypton, kr-81m - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for krypton, kr-81m and what is the scope of patent protection?

Krypton, kr-81m is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for krypton, kr-81m
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 5
Clinical Trials: 2
Patent Applications: 271
DailyMed Link:krypton, kr-81m at DailyMed
Recent Clinical Trials for krypton, kr-81m

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AstraZenecaPhase 1
Simbec ResearchPhase 1
University of Sao PauloPhase 4

See all krypton, kr-81m clinical trials

US Patents and Regulatory Information for krypton, kr-81m

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare MPI KRYPTON 81M GENERATOR krypton, kr-81m GAS;INHALATION 018088-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Krypton, kr-81m Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Krypton and Kr-81m

Introduction

When discussing market dynamics and financial trajectories, it is crucial to distinguish between two distinct substances: Krypton, a noble gas, and Kr-81m, a radioactive isotope of Krypton. Here, we will explore the market and financial aspects of both, highlighting their unique characteristics and applications.

Krypton Market Overview

Market Size and Growth

The Krypton market is expected to exhibit fluctuating growth patterns, influenced by various factors such as economic conditions, supply chain concerns, and geopolitical tensions. Despite these challenges, the market is anticipated to rebound in the latter half of 2024 and beyond, driven by improvements in the economy and alleviation of supply chain issues[1].

Key Challenges

The Krypton industry faces several challenges, including shifting consumer preferences, the need for industrial policy amendments to address environmental concerns, and significant fluctuations in raw material costs. These factors necessitate effective collaboration within the chemical industry and across the value chain to establish a robust regulatory framework[1].

Market Strategy and Drivers

Companies in the Krypton market are focusing on acquiring new technologies, securing raw materials through efficient procurement, enhancing product portfolios, and leveraging capabilities to sustain growth. Regional-specific strategies are being emphasized due to varying economic and social challenges across countries. Government policies promoting the energy transition and the use of bio-chemicals and materials are also driving growth in the manufacturing sector[1].

Geographical Analysis

The global Krypton market is analyzed across various regions, including North America, Europe, Asia Pacific, Middle East, Africa, and LATAM/South and Central America. Each region presents unique market dynamics, with detailed market share statistics, penetration, and shifts in demand for different types, applications, and end-users[1].

Kr-81m Market Dynamics

Medical Applications

Kr-81m, an inert, radioactive gas with a physical half-life of 13 seconds, is primarily used in medical imaging, particularly for evaluating regional lung ventilation. Its advantages over other methods, such as those using xenon-133, include more favorable physical characteristics for imaging, ease of examination performance, improved resolution, and lower doses to patients[3].

Market Size and Growth

The market for Kr-81m is niche and specialized, driven by the demand for advanced medical imaging techniques. The growth of this market is closely tied to advancements in medical technology and the increasing need for precise diagnostic tools.

Regulatory Environment

The use of Kr-81m in medical imaging is subject to strict regulatory oversight to ensure patient safety and efficacy. Regulatory bodies such as the FDA play a crucial role in approving and monitoring the use of radioactive substances in medical procedures.

Financial Trajectory for Krypton

Revenue and Prospective Segments

The global Krypton market revenue is estimated based on market prices, production, supply, demand, and trade logistics across regions. The market is segmented by key product types, dominant applications, and leading end-users. Detailed market share statistics and growth rates from 2024 to 2031 provide a comprehensive financial outlook[1].

Cost Consciousness and Operational Efficiency

Given the challenging economic conditions, companies in the Krypton market are prioritizing cost consciousness and operational efficiency. This involves optimizing procurement and inventory management, enhancing product portfolios, and leveraging technological advancements to sustain growth[1].

Financial Trajectory for Kr-81m

Research and Development

The financial trajectory for Kr-81m is heavily influenced by research and development investments in medical imaging technologies. Funding from healthcare institutions and government agencies supports the advancement of diagnostic tools using Kr-81m, driving its market growth.

Medical Imaging Market

The demand for Kr-81m is closely linked to the broader medical imaging market, which is growing due to the increasing need for precise and efficient diagnostic tools. The financial performance of companies involved in this market is tied to the adoption and integration of Kr-81m in clinical practices.

Key Takeaways

  • Krypton Market: Expected to rebound in the latter half of 2024, driven by economic improvements and supply chain alleviation. Companies are focusing on new technologies, efficient procurement, and enhanced product portfolios.
  • Kr-81m Market: Driven by medical imaging needs, with advantages over other methods like xenon-133. The market is niche and regulated, with growth tied to medical technology advancements.
  • Financial Trajectory: For Krypton, revenue is segmented by product types, applications, and end-users, with a focus on cost efficiency. For Kr-81m, the financial trajectory is influenced by R&D investments and the growing medical imaging market.

FAQs

What are the primary challenges facing the Krypton market?

The Krypton market faces challenges such as shifting consumer preferences, the need for industrial policy amendments, fluctuations in raw material costs, and subdued economic growth.

How is Kr-81m used in medical imaging?

Kr-81m is used to evaluate regional lung ventilation due to its favorable physical characteristics for imaging, ease of examination, improved resolution, and lower doses to patients.

What drives the growth of the Kr-81m market?

The growth of the Kr-81m market is driven by advancements in medical technology and the increasing need for precise diagnostic tools in medical imaging.

How does the regulatory environment impact the use of Kr-81m?

The use of Kr-81m is subject to strict regulatory oversight to ensure patient safety and efficacy, with regulatory bodies like the FDA playing a crucial role.

What are the key financial strategies for companies in the Krypton market?

Companies in the Krypton market are prioritizing cost consciousness, operational efficiency, acquiring new technologies, securing raw materials, and enhancing product portfolios.

Sources

  1. Research and Markets, Krypton Market Size, Competitors, Trends & Forecast Report
  2. Tampa Bay Times, Hundreds died using kratom in Florida. It was touted as safe.
  3. PubMed, Krypton-81m: a better radiopharmaceutical for ...
  4. National Institute on Drug Abuse (NIDA), Kratom
  5. Science | AAAS, Kratom and the FDA

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.